198 related articles for article (PubMed ID: 25880440)
41. Worldwide variation in lynch syndrome screening: case for universal screening in low colorectal cancer prevalence areas.
Kunnackal John G; Das Villgran V; Caufield-Noll C; Giardiello F
Fam Cancer; 2021 Apr; 20(2):145-156. PubMed ID: 32914371
[TBL] [Abstract][Full Text] [Related]
42. A single institution experience in compliance with universal screening for Lynch syndrome in colorectal cancer.
Hill AL; Sumra KK; Russell MM; Yoo J; Ko CY; Hart S; Wainberg Z; Hecht JR; Lin AY
J Gastrointest Surg; 2015 Mar; 19(3):543-50. PubMed ID: 25504462
[TBL] [Abstract][Full Text] [Related]
43. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features.
Jiang W; Cai MY; Li SY; Bei JX; Wang F; Hampel H; Ling YH; Frayling IM; Sinicrope FA; Rodriguez-Bigas MA; Dignam JJ; Kerr DJ; Rosell R; Mao M; Li JB; Guo YM; Wu XY; Kong LH; Tang JH; Wu XD; Li CF; Chen JR; Ou QJ; Ye MZ; Guo FM; Han P; Wang QW; Wan DS; Li L; Xu RH; Pan ZZ; Ding PR;
Int J Cancer; 2019 May; 144(9):2161-2168. PubMed ID: 30521064
[TBL] [Abstract][Full Text] [Related]
44. Selective Versus Universal Screening for Lynch Syndrome: A Six-Year Clinical Experience.
Kidambi TD; Blanco A; Myers M; Conrad P; Loranger K; Terdiman JP
Dig Dis Sci; 2015 Aug; 60(8):2463-9. PubMed ID: 24903654
[TBL] [Abstract][Full Text] [Related]
45. Somatic mismatch repair testing in evaluation of Lynch syndrome: The gap between preferred and current practices.
Williams D; Vilar E; Shakrukh Hashmi S; Choates M; Noblin S; Mork M
J Genet Couns; 2020 Oct; 29(5):728-736. PubMed ID: 31896172
[TBL] [Abstract][Full Text] [Related]
46. Appetite for change? Facilitators and barriers to nutrition guideline implementation in Canadian recreational facilities.
Kirk SFL; Olstad DL; McIsaac JD; Prowse RJL; Caswell S; Hanning R; Raine KD; Mâsse LC; Naylor PJ
Health Promot Int; 2021 Dec; 36(6):1672-1682. PubMed ID: 33615376
[TBL] [Abstract][Full Text] [Related]
47. Barriers and Facilitators Affecting Patient Portal Implementation from an Organizational Perspective: Qualitative Study.
Kooij L; Groen WG; van Harten WH
J Med Internet Res; 2018 May; 20(5):e183. PubMed ID: 29752253
[TBL] [Abstract][Full Text] [Related]
48.
Zammit CM; Creagh NS; McDermott T; Smith MA; Machalek DA; Jennett CJ; Prang KH; Sultana F; Nightingale CE; Rankin NM; Kelaher M; Brotherton JML
Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497850
[TBL] [Abstract][Full Text] [Related]
49. Suboptimal Adherence in Clinical Practice to Guidelines Recommendation to Screen for Lynch Syndrome.
Jain A; Shafer L; Rothenmund H; Kim CA; Samadder J; Gupta S; Singh H
Dig Dis Sci; 2019 Dec; 64(12):3489-3501. PubMed ID: 31187321
[TBL] [Abstract][Full Text] [Related]
50. Different factors identified by stakeholder group for barriers and facilitators to measurement-based care implementation in behavioral health clinics.
Yule AM; Youn SJ; Dean K; Woodward DW; Firmin ES; Kramer J; Stone M; Marques L; Wilens TE
J Clin Psychol; 2024 Mar; 80(3):576-590. PubMed ID: 38230918
[TBL] [Abstract][Full Text] [Related]
51. Universal Versus Targeted Screening for Lynch Syndrome: Comparing Ascertainment and Costs Based on Clinical Experience.
Erten MZ; Fernandez LP; Ng HK; McKinnon WC; Heald B; Koliba CJ; Greenblatt MS
Dig Dis Sci; 2016 Oct; 61(10):2887-2895. PubMed ID: 27384051
[TBL] [Abstract][Full Text] [Related]
52. Underutilization of Lynch syndrome screening in a multisite study of patients with colorectal cancer.
Cross DS; Rahm AK; Kauffman TL; Webster J; Le AQ; Spencer Feigelson H; Alexander G; Meier P; Onitilo AA; Pawloski PA; Williams AE; Honda S; Daida Y; McCarty CA; Goddard KA;
Genet Med; 2013 Dec; 15(12):933-40. PubMed ID: 23639899
[TBL] [Abstract][Full Text] [Related]
53. Comparison of two Lynch screening strategies in endometrial cancer in a California health system.
Lentz SE; Salyer CV; Dontsi M; Armstrong MA; Hoodfar E; Alvarado MM; Avila M; Nguyen NT; Powell CB
Gynecol Oncol; 2020 Jul; 158(1):158-166. PubMed ID: 32386910
[TBL] [Abstract][Full Text] [Related]
54. Factors influencing best-practice guideline implementation: lessons learned from administrators, nursing staff, and project leaders.
Ploeg J; Davies B; Edwards N; Gifford W; Miller PE
Worldviews Evid Based Nurs; 2007; 4(4):210-9. PubMed ID: 18076464
[TBL] [Abstract][Full Text] [Related]
55. An examination of the implementation of a patient navigation program to improve breast and cervical cancer screening rates of Chinese immigrant women: a qualitative study.
Lewis-Thames MW; Tom LS; Leung IS; Yang A; Simon MA
BMC Womens Health; 2022 Feb; 22(1):28. PubMed ID: 35120523
[TBL] [Abstract][Full Text] [Related]
56. Key Informants' Perspectives on Implementing a Comprehensive Lung Cancer Screening Program in a Safety Net Healthcare System: Leadership, Successes, and Barriers.
Mejia MC; Zoorob R; Gonzalez S; Mosqueda M; Levine R
J Cancer Educ; 2022 Aug; 37(4):1144-1151. PubMed ID: 33417096
[TBL] [Abstract][Full Text] [Related]
57. Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through.
Cragun D; DeBate RD; Vadaparampil ST; Baldwin J; Hampel H; Pal T
Genet Med; 2014 Oct; 16(10):773-82. PubMed ID: 24651603
[TBL] [Abstract][Full Text] [Related]
58. The Current Practice of Lynch Syndrome Diagnosis and Management in Italy: A Qualitative Assessment.
Tognetto A; Pastorino R; Castorina S; Condorelli DF; DeCensi A; De Vito C; Magnano A; Scaldaferri F; Villari P; Genuardi M; Boccia S
Public Health Genomics; 2019; 22(5-6):189-207. PubMed ID: 31805557
[TBL] [Abstract][Full Text] [Related]
59. A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T; Huxley N; Hoyle M; Jones-Hughes T; Coelho H; Cooper C; Frayling I; Hyde C
Health Technol Assess; 2014 Sep; 18(58):1-406. PubMed ID: 25244061
[TBL] [Abstract][Full Text] [Related]
60. Factors influencing implementation of a computerized, individualized, culturally tailored lupus decision aid in lupus clinics: a qualitative semi-structured interview study.
Qu H; Hu X; Singh JA
Clin Rheumatol; 2019 Oct; 38(10):2793-2801. PubMed ID: 31222574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
